IMAX Corporation 10-Q Summary: Quarter Ended March 31, 1999
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 1999, for IMAX Corporation, a company engaged in the design, manufacture, and distribution of large-format motion picture systems and films. The company operates globally with significant revenue streams from theater system sales/leases, film production/distribution, and other services.
Key Financial Metrics
| Metric | Q1 1999 | Q1 1998 |
|---|---|---|
| Total Revenue | $36.7 million | $36.4 million |
| Net Earnings | $2.0 million | $4.2 million |
| Earnings Per Share (Diluted) | $0.07 | $0.14 |
| Gross Margin | $16.5 million (45%) | $21.0 million (58%) |
| Operating Cash Flow | ($3.0 million) used | $2.0 million provided |
| Cash and Equivalents | $155.0 million | $63.7 million |
| Total Debt | $300.0 million | $100.0 million* |
| Sales Backlog | $192.9 million | $175.8 million (Dec 1998) |
*Note: Debt increased due to the issuance of $200 million in Senior Notes in December 1998.
Material Changes vs. Prior Period
- Revenue Mix Shift: While total revenue remained relatively flat, Systems revenue declined 15% to $22.4 million due to fewer theater deliveries (6 vs. 8). This was offset by a 21% increase in Film revenue ($8.6 million) and a near doubling of Other revenue ($5.7 million).
- Profitability Decline: Net earnings dropped 52% year-over-year. Gross margin percentage fell from 58% to 45%, driven by the lower-margin mix of film and other revenues and amortization of production costs for the film "T-REX: Back to the Cretaceous."
- Increased Interest Expense: Interest expense rose from $3.3 million to $5.8 million following the December 1998 issuance of $200 million in Senior Notes.
- Cash Position: Cash and cash equivalents increased significantly to $155.0 million, primarily due to the sale of $24.8 million in marketable securities, despite a $3.0 million cash outflow from operating activities.
Guidance, Outlook, and Risks
- Backlog Growth: The sales backlog increased 10% to $192.9 million, representing 80 theater systems, including a significant agreement with Medusa Film SpA for six theaters in Italy.
- Liquidity: Management believes existing cash, marketable securities, and a $1.9 million working capital facility are sufficient for foreseeable needs.
- Year 2000 Compliance: The company has upgraded IT systems and evaluated projection/sound systems. Testing of automation subsystems is expected to be completed by the end of Q2 1999. Risks remain regarding third-party supplier readiness.
- Legal Contingencies:
- Compagnie France Film: Plaintiffs appealed a dismissal of a breach of contract claim. Management expects no material impact.
- Iwerks Entertainment: Plaintiffs appealed a summary judgment dismissal of antitrust claims. Loss amount is indeterminable.
- Cinema Technologies: A trade secrets case was remanded for further proceedings regarding unfair competition; trial set for September 1999.
Investor Verification Checklist
- Verify the sustainability of the 10% backlog growth and the timing of revenue recognition for the 80 contracted systems.
- Monitor the impact of the $200 million Senior Notes on future interest expenses and cash flow.
- Assess the margin recovery potential as the amortization of "T-REX" production costs concludes.
- Review the status of the Cinema Technologies litigation trial scheduled for September 1999.
- Confirm the completion of Year 2000 testing for automation subsystems and critical suppliers by Q2 1999.